$FHLD
Freedom Holdings, Inc.

2022 Q1 Form 10-Q Financial Statement

#000147793223001410 Filed on March 10, 2023

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2019 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $0.00 $7.200K
YoY Change -100.0%
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $3.266K $359.00
YoY Change 809.75%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $65.01K $359.00
YoY Change 18009.47%
Operating Profit -$65.01K -$359.00
YoY Change 18009.47%
Interest Expense $6.005K $2.273K
YoY Change 164.19%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$311.7M -$2.632K
YoY Change 11844267.29%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 328.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $489.00 $1.819K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $489.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $489.00
Total Long-Term Assets $0.00
Total Assets $489.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $68.93K
YoY Change
Accrued Expenses $245.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $337.8K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $337.8K
Total Long-Term Liabilities
Total Liabilities $432.6K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$321.5M
YoY Change
Common Stock $32.87K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$432.1K -$121.2K
YoY Change
Total Liabilities & Shareholders Equity $489.00
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q1 2019 Q3
OPERATING ACTIVITIES
Net Income -$311.7M -$2.632K
YoY Change 11844267.29%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$311.7M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $311.7M
YoY Change
NET CHANGE
Cash From Operating Activities -$311.7M
Cash From Investing Activities
Cash From Financing Activities $311.7M
Net Change In Cash -$1.643K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$311.7M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001386044
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1079116 shares
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54853
dei Entity Registrant Name
EntityRegistrantName
FREEDOM HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
dei Entity Address Address Line1
EntityAddressAddressLine1
263 Tresser Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Stamford
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06901
dei City Area Code
CityAreaCode
260
dei Local Phone Number
LocalPhoneNumber
490-9990
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
328672791 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2132 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
489 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2132 usd
CY2022Q1 us-gaap Assets
Assets
489 usd
CY2021Q3 us-gaap Assets
Assets
2132 usd
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
359 usd
us-gaap Operating Expenses
OperatingExpenses
72714 usd
us-gaap Operating Expenses
OperatingExpenses
714 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-65013 usd
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-359 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-72714 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-714 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
68926 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7861 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
361 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
922 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
244978 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
246208 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
23530 usd
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
337795 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
254991 usd
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
94800 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96933 usd
CY2022Q1 us-gaap Liabilities
Liabilities
432595 usd
CY2021Q3 us-gaap Liabilities
Liabilities
351924 usd
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
710496 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
71 usd
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
328672791 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1079116 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
32868 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
108 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
321006201 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9366161 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-321471175 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9716132 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-432106 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
489 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2132 usd
CY2022Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
CY2021Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
7200 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
12600 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7200 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12600 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
0 usd
CY2021Q1 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
61747 usd
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
68870 usd
us-gaap Professional Fees
ProfessionalFees
0 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3266 usd
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
359 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3844 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
714 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
65013 usd
us-gaap Interest Paid Net
InterestPaidNet
6005 usd
us-gaap Interest Paid Net
InterestPaidNet
6094 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
-311672729 usd
CY2021Q1 fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
0 usd
fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
-311672729 usd
fhld Gain Loss On Related Party Acquisition
GainLossOnRelatedPartyAcquisition
0 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
6005 usd
CY2021Q1 us-gaap Interest Expense
InterestExpense
2273 usd
us-gaap Interest Expense
InterestExpense
9600 usd
us-gaap Interest Expense
InterestExpense
6094 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2632 usd
us-gaap Net Income Loss
NetIncomeLoss
-311755043 usd
us-gaap Net Income Loss
NetIncomeLoss
-6808 usd
CY2022Q1 fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.95
CY2021Q1 fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-1.89
fhld Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
CY2022Q1 fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
328672791 shares
CY2021Q1 fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1077582 shares
fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
164875954 shares
fhld Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
1077582 shares
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-121173 usd
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
240000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-240541 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-121714 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
31400 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-259478 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
fhld Converted Preferred Stock Into Common Amount
ConvertedPreferredStockIntoCommonAmount
0 usd
fhld Acquisition Of Subsidiary Carbon Zero Amount
AcquisitionOfSubsidiaryCarbonZeroAmount
311672729 usd
us-gaap Net Income Loss
NetIncomeLoss
-311755043 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-432106 usd
us-gaap Net Income Loss
NetIncomeLoss
-311755043 usd
us-gaap Net Income Loss
NetIncomeLoss
-6808 usd
fhld Increase Decrease In Accounts Payable And Accruals
IncreaseDecreaseInAccountsPayableAndAccruals
59835 usd
fhld Increase Decrease In Accounts Payable And Accruals
IncreaseDecreaseInAccountsPayableAndAccruals
-1086 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-561 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-311695769 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7894 usd
fhld Proceeds From Paidin Capital Related Party
ProceedsFromPaidinCapitalRelatedParty
0 usd
fhld Proceeds From Paidin Capital Related Party
ProceedsFromPaidinCapitalRelatedParty
12600 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-2133 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-2906 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
23530 usd
fhld Proceeds From Issuance Of Common Stock For Acquisition Of Subsidiary
ProceedsFromIssuanceOfCommonStockForAcquisitionOfSubsidiary
311672729 usd
fhld Proceeds From Issuance Of Common Stock For Acquisition Of Subsidiary
ProceedsFromIssuanceOfCommonStockForAcquisitionOfSubsidiary
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
311694126 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9694 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1643 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1800 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2132 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
489 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1819 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. </p>
CY2022Q1 us-gaap Cash
Cash
489 usd
CY2021Q3 us-gaap Cash
Cash
2132 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-321471175 usd
us-gaap Net Income Loss
NetIncomeLoss
-311755043 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750 usd
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
94800 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96933 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
361 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
922 usd
CY2022Q1 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
95161 usd
CY2021Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
97855 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
244978 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
246208 usd
CY2021Q4 fhld Preferred Stock Description
PreferredStockDescription
On December 30, 2021, the Company converted all of the 710,676 shares of issued and outstanding preferred stock consisting of Series A, B,C and D preferred stock, into 15,920,945 shares of common stock
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
710496 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
328672791 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1079116 shares

Files In Submission

Name View Source Status
0001477932-23-001410-index-headers.html Edgar Link pending
0001477932-23-001410-index.html Edgar Link pending
0001477932-23-001410.txt Edgar Link pending
0001477932-23-001410-xbrl.zip Edgar Link pending
fhld-20220331.xsd Edgar Link pending
fhld_10q.htm Edgar Link pending
fhld-20220331_cal.xml Edgar Link unprocessable
fhld-20220331_def.xml Edgar Link unprocessable
fhld-20220331_lab.xml Edgar Link unprocessable
fhld-20220331_pre.xml Edgar Link unprocessable
fhld_10q_htm.xml Edgar Link completed
fhld_ex311.htm Edgar Link pending
fhld_ex312.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
fhld_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable